2 ND TRENDS IN GLAUCOMA

Size: px
Start display at page:

Download "2 ND TRENDS IN GLAUCOMA"

Transcription

1 PROGRAM 2 ND TRENDS IN GLAUCOMA INTERNATIONAL MEETING ON NEW IMAGING TECHNOLOGIES, LASERS AND GLAUCOMA SURGERY NOVEMBER 18 TH & 19 TH 2016

2 INTRODUCTION 2 nd Trends in Glaucoma is an event aimed at glaucomatologists and, in general, all ophthalmologists interested in this pathology. The meeting objective is to show and discuss in the most dynamic way the latest developments in the diagnosis as well as medical and surgical treatment of different types of glaucoma, with national and international specialists. With the intention that this is an eminently practical meeting, the programme is structured in short presentations and panel discussions, with clinical cases, where our speakers will discuss their approach to the daily management criteria of their patients. We look forward to your attendance and to receiving you at the headquarters of the Barcelona Ocular Microsurgery Institute. ORGANISING COMMITTEE Elena Arrondo Sílvia Freixes Laia Pascual SPEAKERS Ike K. Ahmed, Toronto Alfonso Antón, Barcelona José I. Belda, Alicante María Isabel Canut, Barcelona Marta Castany, Barcelona Susana Duch, Barcelona Pedro Corsino Fernández Vila, Pontevedra Alfonso Gil, Bilbao Félix Gil Carrasco, Mexico City M. Javier González, Vigo Francisco J. Goñi, Barcelona Jost Jonas, Heidelberg Maria Zakharova, Moscow Jordi Loscos, Barcelona Alfredo Mannelli, Barcelona José María Martínez de la Casa, Madrid Javier Moreno Montañés, Pamplona Maria Jesús Muniesa, Lleida Francisco Muñoz Negrete, Madrid Luis E. Pablo Júlvez, Zaragoza Gema Rebolleda, Madrid Pedro Pablo Rodríguez, Oviedo Cecilia Salinas, Barcelona Silvia Sanz, Barcelona Konrad Schargel, Alicante Ingeborg Stalmans, Leuven Miguel Ángel Teus, Madrid J. Aritz Urcola, San Sebastián Alicia Verdugo, Girona The event will feature simultaneous translation: English-Spanish / Spanish-English

3 FRIDAY, 18 TH NOVEMBER 7:30 a.m REGISTRATION 8:15 a.m. WELCOME 8:30 a.m SESSION I. WHAT NEW TECHNOLOGIES PROVIDE WHEN DIAGNOSING GLAUCOMA. Moderators: Dr Elena Arrondo and Dr Jost Jonas Hourly IOP monitoring before and after surgery with SENSIMED Triggerfish. Dr Maria Zakharova Cerebrospinal fluid pressure in the pathogenesis of glaucomatous optic neuropathy. Dr Jost Jonas New aspects in the anatomy of optic nerve head with respect to glaucoma and myopia. Dr Jost Jonas The lamina cribosa and its neighbours: what we can learn from them. Dr Gema Rebolleda Progression detection with RNFL and GCC measurement. Artifacts and software errors. Dr Javier Moreno Montañés Angio-OCT: Is it a useful tool? Dr Sílvia Freixes OCT in non-penetrating surgery. Dr. J. Aritz Urcola Update on progression with visual field testing. Dr Francisco J. Goñi Usefulness of UBM in glaucoma patients. Dr Cecilia Salinas 10:30 a.m. COFFEE BREAK 11 am KEYNOTE LECTURE. Current Trends in Glaucoma Surgery. Dr. Ike K. Ahmed 11:45 a.m. SESSION II. INDICATIONS AND RESULTS WITH THE NEW LASERS FOR TRABECULOPLASTY: WHEN TO PERFORM IT. Moderators: Dr José I. Belda and Dr Alfonso Antón Selective Laser Trabeculoplasty (SLT). Dr Konrad Schargel Patterned Laser Trabeculoplasty ( PLT). Dr Alicia Verdugo Micropulse Laser Trabeculoplasty ( MLT). Dr Laia Pascual 12:30 p.m. SESSION III: CURRENT MEDICAL TREATMENT IN GLAUCOMA. SUSTAINED-RELEASE DEVICES AND NEUROPROTECTION. Moderators: Dr Francisco J. Goñi and Dr Susana Duch Learning to coexist: ocular surface and glaucoma. Dr Susana Duch New ways of glaucoma drug release. Dr Pedro C. Fernández Vila Neuroprotection: present and future. Francisco J. Goñi Non-conventional therapeutic alternative for pressure control in patients with glaucoma. Dr Félix Gil Carrasco Clinical cases 1:30 p.m. LUNCH

4 3:00 p.m. SESSION IV. GLAUCOMA SURGERY I. MIGS. Moderators: Dr Ike K. Ahmed and Dr Miguel Ángel Teus The scientific rationality of using MIGS. Dr Pedro C. Fernández Vila When to add a Cypass to a cataract surgery. Dr Alfonso Antón My experience with istent. Dr José I. Belda What do the other MIGS provide?. Dr José María Martínez de la Casa Clinical cases. Dr Ike Ahmed 4:00 p.m. COFFEE BREAK 4:30 p.m. SESSION V. GLAUCOMA SURGERY II. MIGS PLUS AND EX-PRESS. Moderators: Dr Marta Castany and Dr Laia Pascual When and how to implant an Ex-Press. Dr Maria Jesús Muniesa Long-term results with Ex-Press mini shunt implantation. Dr Maria Zakharova Results of the spanish XEN study. Dr Miguel Ángel Teus Phase IV XEN study. Prof. Ingeborg Stalmans 5:30 p.m. SESIÓN VI. BLEB HEALING. Moderators: Prof. Ingeborg Stalmans and Dr Jordi Loscos Wound-healing in my glaucoma surgery. Prof. Ingeborg Stalmans Optimizing filtering surgery. Ologen, mitomycin and anti-vegf. Dr Miguel Ángel Teus My Deep Sclerectomy is starting to fail: new surgical approach. Dr Jordi Loscos Prevention and treatment of a failing glaucoma drainage device. Dr Félix Gil Carrasco 7:00 p.m. END OF SESSION

5 SATURDAY, 19 TH NOVEMBER 9:00 a.m. SESSION VII. GLAUCOMA SURGERY III. Moderators: Dr Gema Rebolleda and Dr M. Isabel Canut High myopia and glaucoma: key points. Dr Pedro P. Rodríguez Management of pigmentary glaucoma. Dr Sílvia Freixes Are there any advantages of the suprachoroidal implant in deep sclerectomy? Dr Jordi Loscos Transition to canaloplasty: how to get started without perishing. Dr M. Javier González Angle-closure glaucoma: how to manage it. Dr Alfonso Gil Phacoemulsification in patients with prior filtering surgery. Dr Luis E. Pablo Júlvez Keratoprosthesis and glaucoma. Dr Elena Arrondo Early hypotony, what now? Dr Marta Castany Late hypotony: solving problematic blebs. Dr Alfonso Gil 11:00 a.m. COFFEE BREAK 11:30 a.m. SESSION VIII. PROS AND CONS. Moderators: Dr Alfredo Mannelli and Dr Sílvia Freixes One test for each patient: imaging or visual fields? Dr Alfonso Antón and Dr Francisco J. Goñi Drops versus laser: which to start with. Dr Silvia Sanz and Dr Konrad Schargel Conjunctival bleb yes or no : deep sclerectomy vs canaloplasty. Dr Elena Arrondo and Dr. J. Aritz Urcola What to choose: trabeculectomy or Ex-Press? Dr Luis E. Pablo Júlvez and Dr Francisco Muñoz Negrete My favourite drainage implant: Ahmed versus Baerveldt. Dr Félix Gil Carrasco and Dr Susana Duch Advanced glaucoma: surgery yes or not? Dr María Isabel Canut and Dr Pedro C. Fernández Vila 1:00 p.m. CLOSURE REGISTRATION Before 17 th September 300 After 17 th September 350 Online registration: For more information, contact the IMO s Communication Department: Ana Cristina de Arriba: events@imo.es Marta Rodríguez: prensa@imo.es

6 WHERE WE ARE The event will be held at the IMO s Convention Centre, which is located near Junction 7 of Barcelona s Ronda de Dalt ring road (mountain side) and can be accessed directly from Josep Maria Lladó street, number The Institute features parking facilities and a cafeteria The nearest stops are: Stop 3191: Josep Maria Lladó-Bellesguard. Bus line 196. Stop 1540: Bellesguard roundabout. Bus line 60. Stop 0071: Ronda de Dalt-Bellesguard. Bus lines 6, 196 and 123. Taxis can be booked at the IMO s reception.

2nd Trends in Glaucoma

2nd Trends in Glaucoma URL: www.eyefox.com/5729 zurück 2nd Trends in Glaucoma International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery Symposium 18.11.2016, 09:00-19.11.2016, 13:00 08035 Barcelona, Spanien

More information

PROGRAMME GLAU COMA 3RDTRENDS IN. International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery. 9 th & 10 th November

PROGRAMME GLAU COMA 3RDTRENDS IN. International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery. 9 th & 10 th November PROGRAMME 3RDTRENDS IN GLAU COMA International Meeting on New Imaging Technologies, Lasers and Glaucoma Surgery 9 th & 10 th November ORGANIZING COMMITTEE IMO s Glaucoma Department: Dr Elena Arrondo Dr

More information

Dra. Elena Arrondo. License Number:

Dra. Elena Arrondo. License Number: Dra. Elena Arrondo The Glaucoma Department of the IMO, Institute of Ocular Microsurgery. Lecturer in the Glaucoma Master s Degree of the Institute of Ocular Microsurgery. License Number: 32.348 Curriculum

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Aqueous Shunts and Devices for Glaucoma File Name: Origination: Last CAP Review: Next CAP Review: Last Review: aqueous_shunts_and_devices_for_glaucoma 3/2010 6/2017 6/2018 6/2017

More information

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD Glaucoma Surgical Treatments Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD Disclosures Murray Fingeret Consultant Bausch & Lomb, Alcon, Allergan Justin Schweitzer Allergan, Glaukos, Bausch and

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Protocol Aqueous Shunts and Stents for Glaucoma (90321) Medical Benefit Effective Date: 04/01/14 Next Review Date: 01/15 Preauthorization No Review Dates: 03/10, 03/11, 07/11, 01/12, 09/12, 01/13, 01/14

More information

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma)

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma) Protocol Aqueous Shunts and Stents for Glaucoma (90321) (Formerly Aqueous Shunts for Glaucoma) Medical Benefit Effective Date: 01/01/13 Next Review Date: 01/14 Preauthorization* No Review Dates: 03/10,

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 1/2018 Origination: 9/2008 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

FINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona

FINAL PROGRAM TRENDS IN SURGICAL III. Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona FINAL PROGRAM III TRENDS IN SURGICAL & MEDICAL RETINA Live Surgery and Round Tables Borja Corcóstegui, MD IMO - Barcelona May 29th & 30th 2015, Barcelona Join the IMO team and eminent guest surgeons in

More information

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures Optometrist's Guide to Glaucoma Surgery Anthony DeWilde, OD FAAO I have no financial disclosures 1 2 Goals Glaucoma Philosophy Glaucoma can be a visually debilitating disease. How glaucoma surgery works

More information

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY Clinical criteria used to make utilization review decisions are based on credible scientific evidence published in peer reviewed medical literature generally recognized by the medical community.

More information

GENERAL INFORMATION GLAUCOMA GLAUCOMA

GENERAL INFORMATION GLAUCOMA GLAUCOMA GENERAL INFORMATION GLAUCOMA GLAUCOMA WHAT IS GLAUCOMA? Glaucoma is commonly known as the sneak thief of sight because it can cause irreversible vision loss without any obvious symptoms. The term glaucoma

More information

Aqueous Shunts and Stents for Glaucoma. Populations Interventions Comparators Outcomes Individuals: With refractory open-angle glaucoma.

Aqueous Shunts and Stents for Glaucoma. Populations Interventions Comparators Outcomes Individuals: With refractory open-angle glaucoma. Protocol Aqueous Shunts and Stents for Glaucoma (90321) Medical Benefit Effective Date: 04/01/15 Next Review Date: 11/18 Preauthorization No Review Dates: 03/10, 03/11, 07/11, 01/12, 09/12, 01/13, 01/14,

More information

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK Financial Disclosure None to be Declared Presentation overview Glaucoma Surgical History Complications of trabeculectomy Express Device Specifications Surgical Steps Clinical advantages, indications and

More information

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing

Glaucoma. How is Glaucoma Diagnosed? Glaucoma Testing Glaucoma How is Glaucoma Diagnosed? Glaucoma Testing There is no single test for glaucoma. The diagnosis is made by evaluating the patient from a number of perspectives, using specialized instruments.

More information

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment

MEDICAL POLICY. SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) POLICY NUMBER: CATEGORY: Technology Assessment MEDICAL POLICY PAGE: 1 OF: 8 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy criteria are not applied.

More information

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110 Subject Index Ab externo Schlemm canal surgery, see Canaloplasty, Viscocanalostomy Ab interno Schlemm canal surgery, see istent, Trabectome Adjustable sutures 14, 15 AGV glaucoma drainage implants 43,

More information

Surgical Techniques In Ophthalmology: Glaucoma Surgery READ ONLINE

Surgical Techniques In Ophthalmology: Glaucoma Surgery READ ONLINE Surgical Techniques In Ophthalmology: Glaucoma Surgery READ ONLINE If you are searched for a ebook Surgical Techniques in Ophthalmology: Glaucoma Surgery in pdf form, then you've come to the faithful website.

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 8/2018 Origination: 9/2008 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Preliminary Scientific Program Update February 24, 2014

Preliminary Scientific Program Update February 24, 2014 Preliminary Scientific Program Update February 24, 2014 Saturday, June 7 15.45-17.45 SFG (Société Française du Glaucome) and SFO (Société Française d'ophtalmologie) Session 18.00 Welcome Reception (Acropolis

More information

Micro-Invasive Glaucoma Surgery (Aqueous Stents)

Micro-Invasive Glaucoma Surgery (Aqueous Stents) Micro-Invasive Glaucoma Surgery (Aqueous Stents) Policy Number: Original Effective Date: MM.06.029 02/01/2019 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2019 Section:

More information

Aqueous Shunts and Stents for Glaucoma. Description

Aqueous Shunts and Stents for Glaucoma. Description Subject: Aqueous Shunts and Stents for Glaucoma Page: 1 of 13 Last Review Status/Date: June 2015 Aqueous Shunts and Stents for Glaucoma Description Glaucoma is not a single entity; there are many subcategories

More information

Aqueous Shunts and Stents for Glaucoma

Aqueous Shunts and Stents for Glaucoma Aqueous Shunts and Stents for Glaucoma Policy Number: 9.03.21 Last Review: 1/2014 Origination: 9/2008 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

WGA. The Global Glaucoma Network

WGA. The Global Glaucoma Network The Global Glaucoma Network Fort Lauderdale April 30, 2005 Indications for Surgery 1. The decision for surgery should consider the risk/benefit ratio. Note: Although a lower IOP is generally considered

More information

Micro-Invasive Glaucoma Surgery (Aqueous Stents)

Micro-Invasive Glaucoma Surgery (Aqueous Stents) Micro-Invasive Glaucoma Surgery (Aqueous Stents) Policy Number: Original Effective Date: MM.06.029 02/01/2019 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 02/01/2019 Section:

More information

Gastrointestinal Oncology

Gastrointestinal Oncology 2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting

More information

Save time at your check-in and register online before your appointment! It s as easy as 1-2-3

Save time at your check-in and register online before your appointment! It s as easy as 1-2-3 Save time at your check-in and register online before your appointment! It s as easy as 1-2-3 1. Go online to www.blackhillseyes.com 2. Click this logo on our home page for the link to register: 3. Set-up

More information

ICGS 2018 September

ICGS 2018 September International Congress THURSDAY, SEPTEMBER 6, 2018 ICGS 2018 September 6-8 2018 SCIENTIFIC PROGRAM International Congress THURSDAY, SEPTEMBER 6, 2018 INTRODUCTION DAY - THE WORLD NOW 14.00 OPENING AND

More information

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY?

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY? XEN GEL STENT OMAHA AND LINCOLN EYE AND LASER INSTITUTES MARK R. YOUNG, M.D. April 7, 2018 QUESTION: Why are we looking for alternatives to current glaucoma treatment? Look at current surgical glaucoma

More information

1/16/2018. Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas

1/16/2018. Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas Brett J. Teague, M.D. Big Country Eye Center Abilene, Texas I developed the course material/information independently No relevant financial relationship exists by anyone in control of presentation content

More information

Review of the Ahmed versus Baerveldt study 5-year treatment outcomes

Review of the Ahmed versus Baerveldt study 5-year treatment outcomes Perspective Page 1 of 5 Review of the Ahmed versus Baerveldt study 5-year treatment outcomes Victor Koh 1,2, Cecilia Maria Aquino 1, Paul Chew 1,2 1 Department of Ophthalmology, National University Hospital,

More information

sad EFFECTIVE DATE: POLICY LAST UPDATED:

sad EFFECTIVE DATE: POLICY LAST UPDATED: Medical Coverage Policy Aqueous Shunts and Stents for Glaucoma sad EFFECTIVE DATE: 08 19 2014 POLICY LAST UPDATED: 09 18 2018 OVERVIEW Glaucoma surgery is intended to reduce intraocular pressure (IOP)

More information

Glaucoma: From Cutting Edge to Practice

Glaucoma: From Cutting Edge to Practice September 22-24, 2011 Glaucoma: From Cutting Edge to Practice Program The Westin Ottawa 11 Colonel By Drive (4th Floor Ballrooms Confederation I/Provinces) Ottawa, ON Faculté de médecine Presented by the

More information

PROGRAMME April 26 th & 27 th 2019

PROGRAMME April 26 th & 27 th 2019 PROGRAMME April 26 th & 27 th 2019 LIVE SURGERY REJUVENATION WORKSHOPS Dr Ramón Medel IMO barcelonaoculoplastics.com ORGANIZING COMMITTEE Dr Ramón Medel Dr Juan Carlos Sánchez Dr Luz María Vásquez NATIONAL

More information

CURRICULUM VITAE. Marcos Muñoz M.D.

CURRICULUM VITAE. Marcos Muñoz M.D. CURRICULUM VITAE Marcos Muñoz M.D. Marcos Muñoz. Curriculum Vitae 2 1. WORK EXPERIENCE 2015- present Head of Emergency Department Institut Català de Retina (Barcelona, Spain) 2014-2015 Head of General

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Last Review: September 2016 Next Review: September 2017 Related Policies 9.03.06 Opthalmalologic Techniques for Evaluating Glaucoma 9.03.26 Viscocanalostomy and Canaloplasty Aqueous

More information

XEN-IMPLANT: MINIMALLY INVASIVE SURGERY FOR THE TREATMENT OF GLAUCOMA

XEN-IMPLANT: MINIMALLY INVASIVE SURGERY FOR THE TREATMENT OF GLAUCOMA XEN-IMPLANT: MINIMALLY INVASIVE SURGERY FOR THE TREATMENT OF GLAUCOMA SAOO-Kongress 1.3.18 Dr. André Mermoud, Glaucoma Center, VISIO-Lausanne, Switzerland The 4 aims of any glaucoma surgery are: The 4

More information

Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision

Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision 9.03.21 Aqueous Shunts and Stents for Glaucoma Section 9.0 Other Subsection 9.03 Vision Effective Date January 30, 2015 Original Policy Date January 30, 2015 Next Review Date January 2016 Description Glaucoma

More information

GLAUCOMA SURGICAL TREATMENTS

GLAUCOMA SURGICAL TREATMENTS GLAUCOMA SURGICAL TREATMENTS UnitedHealthcare Commercial Medical Policy Policy Number: OPT014 Effective Date: May 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS... 1 COVERAGE

More information

Gastrointestinal Oncology

Gastrointestinal Oncology 1stMD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era ra o f Pe Perss on onal aliz ized ed M edicine PRELIMINARY PROGRAM Madrid, 29 November -

More information

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy

Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy Aqueous Shunts and Stents for Glaucoma Corporate Medical Policy File name: Aqueous Shunts and Stents for Glaucoma File code: UM.SURG.18 Origination: New Policy Last Review: 06/2017 Next Review: 06/2018

More information

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy.

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy. Medical Policy Title: Aqueous Shunts and ARBenefits Approval: 10/26/2011 Devices for Glaucoma Effective Date: 01/01/2012 Document: ARB0168 Revision Date: Code(s): 66174, Transluminal dilation of aqueous

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of ab interno supraciliary microstent insertion with phacoemulsification for primary

More information

CLASS-y Laser Treats Glaucoma

CLASS-y Laser Treats Glaucoma Article # 404 Comments About the Author Released: Author: Category: March 12th, 2014 Issue #0314 Ehud Assia Feature S S S S S CLASS-y Laser Treats Glaucoma Transforming complex, invasive and risky glaucoma

More information

MEDICAL POLICY POLICY TITLE AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA POLICY NUMBER

MEDICAL POLICY POLICY TITLE AQUEOUS SHUNTS AND STENTS FOR GLAUCOMA POLICY NUMBER Original Issue Date (Created): October 1, 2010 Most Recent Review Date (Revised): January 28, 2014 Effective Date: May 1, 2014 I. POLICY Insertion of aqueous shunts approved by the U.S. Food and Drug Administration

More information

MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) EFFECTIVE DATE: 03/20/14 REVISED DATE: 03/19/15, 03/17/16, 4/20/17, 04/19/18

MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES (STENTS AND SHUNTS) EFFECTIVE DATE: 03/20/14 REVISED DATE: 03/19/15, 03/17/16, 4/20/17, 04/19/18 MEDICAL POLICY SUBJECT: AQUEOUS DRAINAGE DEVICES PAGE: 1 OF: 11 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Developments in Glaucoma Surgery

Developments in Glaucoma Surgery Developments in Glaucoma Surgery Marlene R. Moster, MD Professor of Ophthalmology Thomas Jefferson University School of Medicine Wills Eye Hospital Philadelphia, PA When is surgery indicated? Poor control

More information

Course # Glaucoma Pearls: From OGS to ARVO

Course # Glaucoma Pearls: From OGS to ARVO Course # 101 DISCLOSURE STATEMENT Consultant-Aerie, Allergan, B + L, Carl Zeiss Meditec, Heidelberg Engineering, Novartis Pharma, Topcon Course Title: Lecturer: Glaucoma Pearls: From OGS to ARVO Murray

More information

GLAUCOMA SURGICAL TREATMENTS

GLAUCOMA SURGICAL TREATMENTS GLAUCOMA SURGICAL TREATMENTS UnitedHealthcare Oxford Clinical Policy Policy Number: VISION 023.20 T2 Effective Date: April 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 CONDITIONS OF COVERAGE...

More information

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL)

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL) MIGS: How did we get here? GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: 55570-GL) John Gelvin, O.D., F.A.A.O. MOYES EYE CENTER Kansas City, Missouri jgelvin@moyeseye.com 1. Tube vs Trabeculectomy?

More information

in the Napa Valley Meritage Resort Napa, California

in the Napa Valley Meritage Resort Napa, California Beckman Vision Center Department of Ophthalmology University of California San Francisco School of Medicine University of California San Francisco GLAUCOMA UPDATE in the Napa Valley FRIDAY - SATURDAY Napa,

More information

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014

From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 1. This course is designed to review the important ophthalmic literature that was released between October 2013

More information

>$500m. Assessing New Implants. Minimally-Invasive Surgery & Other new devices -a Foretaste

>$500m. Assessing New Implants. Minimally-Invasive Surgery & Other new devices -a Foretaste Minimally-Invasive Surgery & Other new devices -a Foretaste Keith Barton Consultant Ophthalmologist Moorfields Eye Hospital, London Market capitalisation of new glaucoma surgical device companies >$500m

More information

LIVING WITH GLAUCOMA Volume 27, Number 3 Spring 2013

LIVING WITH GLAUCOMA Volume 27, Number 3 Spring 2013 LIVING WITH GLAUCOMA Volume 27, Number 3 Spring 2013 THE COMBINATION OPERATION Cataract and I-Stent I ponder the word program. You re handed a program at the theater, you develop a college program. Your

More information

Written by Administrator Wednesday, 13 January :27 - Last Updated Thursday, 21 January :34

Written by Administrator Wednesday, 13 January :27 - Last Updated Thursday, 21 January :34 angle closure glaucoma A type of glaucoma caused by a sudden and severe rise in eye pressure. Occurs when the pupil enlarges too much or too quickly, and the outer edge of the iris blocks the eye s drainage

More information

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar Tubes, Ties and Videotape: Surgical Video of Glaucoma Implants and Financial Disclosure I have no financial interests or relationships to disclose. Herbert P. Fechter MD, PE Eye Physicians and Surgeons

More information

Optometric Glaucoma Foundation

Optometric Glaucoma Foundation Optometric Glaucoma Foundation In partnership with the 2nd Annual Educators Program September 8, 2018 489 Minor Hall School of Optometry University of California, Berkeley Berkeley, CA Optometric Glaucoma

More information

Contents Optic Nerve: The Glaucomatous Optic Nerve Optic Nerve: Clinical Examination Optic Nerve: Heidelberg Retinal Tomography

Contents Optic Nerve: The Glaucomatous Optic Nerve Optic Nerve: Clinical Examination Optic Nerve: Heidelberg Retinal Tomography Contents 1 Optic Nerve: The Glaucomatous Optic Nerve................... 1 1.1 Why Is the Optic Nerve Important in the Diagnosis and Management of Glaucoma?............................ 1 References.................................................

More information

LION-HEART. Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure

LION-HEART. Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure LION-HEART Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure Multicentre, randomized, double-blind, parallel group, placebo-controlled

More information

MIGS Rapid Fire Outline 1 st talk: Goniotomy, Lisa Young, OD, FAAO

MIGS Rapid Fire Outline 1 st talk: Goniotomy, Lisa Young, OD, FAAO Rapid Fire MIGS A Modern Solution to a Complex Problem Course Description: Minimally (or Micro-) Invasive Glaucoma Surgeries, or MIGS, are an increasingly popular treatment modality in the management of

More information

Hydrus. What is a Hydrus Microstent? By Nathan Kerr and Keith Barton. Eye words to know. MIGS.org

Hydrus. What is a Hydrus Microstent? By Nathan Kerr and Keith Barton. Eye words to know. MIGS.org MIGS.org Hydrus By Nathan Kerr and Keith Barton What is a Hydrus Microstent? The Hydrus Microstent is a small flexible scaffold inserted into the natural drainage channel of the eye to lower eye pressure

More information

DVD Contents. Chapter 3: Indications for Trabeculectomy and Tubes: Which to Choose, When and How? Chapter 21: Implants in Deep Sclerectomy

DVD Contents. Chapter 3: Indications for Trabeculectomy and Tubes: Which to Choose, When and How? Chapter 21: Implants in Deep Sclerectomy DVD Contents Chapter 3: Indications for Trabeculectomy and Tubes: Which to Choose, When and How? Pigs Eye Trabeculectomy Chapter 5: New Surgical Techniques Hydrus Cy-Pass Xen Chapter 7: Selective Laser

More information

Barcelona, 3 4 June 2011 Auditorium IMO (Institut de Microcirurgia Ocular)

Barcelona, 3 4 June 2011 Auditorium IMO (Institut de Microcirurgia Ocular) Trends in Surgical and Medical Retina Barcelona, 3 4 June 2011 Auditorium IMO (Institut de Microcirurgia Ocular) www.esaso.ch 1 Trends in Surgical and Medical Retina Trends in Surgical and Medical Retina

More information

Ab-Interno Canaloplasty A Comprehensive Minimally Invasive Glaucoma Surgery

Ab-Interno Canaloplasty A Comprehensive Minimally Invasive Glaucoma Surgery Ab-Interno Canaloplasty A Comprehensive Minimally Invasive Glaucoma Surgery AB-INTERNO CANALOPLASTY: TREATMENT STEPS Primary open-angle glaucoma (POAG) is a sightthreatening condition caused by suboptimal

More information

(Eye)Drop It Like It s Hot New & Exciting Advancements in Glaucoma

(Eye)Drop It Like It s Hot New & Exciting Advancements in Glaucoma Disclosures (Eye)Drop It Like It s Hot New & Exciting Advancements in Glaucoma I have no financial ties or relationships to any of the companies or products mentioned in this lecture. Although if one wants

More information

Cataract Surgery in Eyes with Glaucoma

Cataract Surgery in Eyes with Glaucoma Cataract Surgery in Eyes with Glaucoma Malik Y. Kahook, MD The Slater Family Endowed Chair in Ophthalmology Professor of Ophthalmology Vice Chair, Clinical and Translational Research University of Colorado

More information

CHARTING THE NEW COURSE FOR MIGS

CHARTING THE NEW COURSE FOR MIGS CHARTING THE NEW COURSE FOR MIGS SEE WHAT S ON THE HORIZON CyPass Micro-Stent the next wave in micro-invasive glaucoma surgery. MICRO-INVASIVE GLAUCOMA SURGERY (MIGS) OFFERS A REVOLUTIONARY APPROACH TO

More information

COMMITMENT TO MEDICAL EXCELLENCE

COMMITMENT TO MEDICAL EXCELLENCE COMMITMENT TO MEDICAL EXCELLENCE The only ophthalmology centre in Catalonia accredited with the quality seal of the Joint Commission International IMO Emergency Department The IMO s Ophthalmic Emergency

More information

Microinvasive surgical

Microinvasive surgical Improved efficacy expected with second-generation microinvasive glaucoma surgery (MIGS) devices BY ROD MCNEIL Microinvasive surgical approaches to primary openangle glaucoma (POAG) offer minimally traumatic

More information

Educating in Radiosurgery Course

Educating in Radiosurgery Course www.radiocirugia2012.com Educating in Radiosurgery Course programme Educating in Radiosurgery Course Associates Technical Secretariat: TISA Congresos - Avda. de la Libertad, 17-3 - 20004 DONOSTIA -SAN

More information

Considerations in the Cataract Patient with Glaucoma. Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT

Considerations in the Cataract Patient with Glaucoma. Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT Considerations in the Cataract Patient with Glaucoma Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut Fairfield, CT Financial Disclosure Dr. Noecker has been a paid consultant to Allergan,

More information

The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3%

The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3% The second most common causes of blindness worldwide. ( after cataract) The commonest cause of irreversible blindness in the world Estimated that 3% of our population age > 40 have glaucoma In the past:

More information

ANSWERS TO YOUR MOST COMMON GLAUCOMA QUESTIONS

ANSWERS TO YOUR MOST COMMON GLAUCOMA QUESTIONS For Your Eyes Only: ANSWERS TO YOUR MOST COMMON GLAUCOMA QUESTIONS www.kremereyecenter.com / 800-694-3937 1 Table of Contents Introduction... 3 Glaucoma Defined... 4 Symptoms of Glaucoma... 6 Treatment

More information

Proposal for the Introduction of New Health Technologies within the Specialist Health Service

Proposal for the Introduction of New Health Technologies within the Specialist Health Service Proposal for the Introduction of New Health Technologies within the Specialist Health Service Important information look at this first! Submitted proposals for national method assessments will be published

More information

Application Request to Hold an Add-On ICS Educational Course. Yes

Application Request to Hold an Add-On ICS Educational Course. Yes Application Request to Hold an Add-On ICS Educational Course Name of ICS Member requesting application: Country in which course is to be held: Proposed City Proposed Dates Proposed Venue Accommodation

More information

Note: For information about other proposed surgical procedures for treatment of glaucoma see: SURG Viscocanalostomy and Canaloplasty

Note: For information about other proposed surgical procedures for treatment of glaucoma see: SURG Viscocanalostomy and Canaloplasty Subject: Document#: Publish Date: 02/28/2018 Status: Reviewed Last Review Date: 01/25/2018 Description/Scope This document addresses surgical devices used in the treatment of refractory open-angle glaucoma

More information

Collaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012

Collaboration in the care of glaucoma patients and glaucoma suspects. Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012 Collaboration in the care of glaucoma patients and glaucoma suspects Barry Emara MD FRCS(C) Nico Ristorante November 29, 2012 Goals of Collaboration Patient-centred and evidence based approach Timely access

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary

More information

TRABECULECTOMY THE BEST AND WORST CANDIDATES

TRABECULECTOMY THE BEST AND WORST CANDIDATES TRABECULECTOMY THE BEST AND WORST CANDIDATES MICHAEL F. OATS, MD OPHTHALMIC CONSULTANTS OF BOSTON ASCRS 2014 FINANCIAL DISCLOSURES None TRABECULECTOMY Performed for over 100 years Most commonly performed

More information

Cataract-Glaucoma Preoperative considerations. Dimitrios Mikropoulos

Cataract-Glaucoma Preoperative considerations. Dimitrios Mikropoulos Cataract-Glaucoma Preoperative considerations Dimitrios Mikropoulos Cataract surgery alone Trabeculectomy alone Combined surgery The cataract is visually significant, and the glaucoma is well controlled

More information

Secondary Glaucomas. Mr Nick Strouthidis MBBS MD PhD FRCS FRCOphth FRANZCO Consultant Ophthalmologist, Glaucoma Service, Moorfields Eye Hospital

Secondary Glaucomas. Mr Nick Strouthidis MBBS MD PhD FRCS FRCOphth FRANZCO Consultant Ophthalmologist, Glaucoma Service, Moorfields Eye Hospital Secondary Glaucomas Mr Nick Strouthidis MBBS MD PhD FRCS FRCOphth FRANZCO Consultant Ophthalmologist, Glaucoma Service, Moorfields Eye Hospital Introduction: What is glaucoma? Glaucoma is the name given

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension 1.1 Short title Glaucoma 2 Background

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Viscocanalostomy and Canaloplasty File Name: Origination: Last CAP Review: Next CAP Review: Last Review: viscocanalostomy_and_canaloplasty 11/2011 6/2017 6/2018 6/2017 Description

More information

The Early Nutrition Academy (ENA) was established in the context of sustainability actions of

The Early Nutrition Academy (ENA) was established in the context of sustainability actions of Early Nutrition Academy Symposium on Nutritional Programming, from theory to practice April 18 th April 20 th 2012, Reus (Spain) Symposium Venue: School of Medicine, Universitat Rovira I Virgili The Early

More information

CONTENTS. Surgical Anatomy David Fleischman, MD and John P. Berdahl, MD

CONTENTS. Surgical Anatomy David Fleischman, MD and John P. Berdahl, MD CONTENTS Dedication... About the Editor... About the Associate Editors... Contributing Authors... Introduction... xxv Chapter 1 Introduction to Basic Concepts of Glaucoma Surgery... I The Surgical Decision-Making

More information

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma Financial Disclosures for Mitch Ibach OD, FAAO MIGs in the BIGs A professional level understanding of MIGs Glaukos Alcon Equinox LLC. Mitch Ibach OD, FAAO Vance Thompson Vision Human Cost of Glaucoma WHY

More information

III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins)

III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins) III WORKSHOP INTERNATIONAL BIOCAPS 2015 (& 1st Spanish National Symposium in Incretins) TITLE: DIABESITY new strategic targets and incretins. DATES: 22-24th/OCTOBER/2015. ORGANIZING INSTITUTION: Instituto

More information

Landmark Tube Trials

Landmark Tube Trials SECTION EDITOR: BARBARA SMIT, MD, PhD Landmark Tube Trials A review of key findings from recent multicenter randomized clinical trials involving tube shunts. BY AMBIKA HOGUET, MD, AND STEVEN J. GEDDE,

More information

II CANCER CELL SIGNALING PATHWAYS CONFERENCE

II CANCER CELL SIGNALING PATHWAYS CONFERENCE II CANCER CELL SIGNALING PATHWAYS CONFERENCE AN IN DEPTH LOOK AT LUNG, MELANOMA, GLIOBLASTOMA, BREAST, HEAD & NECK SQUAMOUS CELL CANCERS Fundació Institut d Investigació en Ciències de la Salut Germans

More information

Ophthalmology. Books Journals Electronic Resources. Visit to order these and other new and bestselling titles in Ophthalmology

Ophthalmology. Books Journals Electronic Resources. Visit  to order these and other new and bestselling titles in Ophthalmology Ophthalmology Books Journals Electronic Resources 2017 Visit www.thieme.com to order these and other new and bestselling titles in Ophthalmology Interdisciplinary Management of Orbital Diseases Textbook

More information

and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT, LONG-TERM IOP CONTROL

and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT, LONG-TERM IOP CONTROL FOR THE REDUCTION OF IOP IN MILD TO MODERATE PRIMARY OPEN-ANGLE GLAUCOMA AT THE TIME OF CATARACT SURGERY and done ONE CYPASS MICRO-STENT IS ALL IT TAKES TO DELIVER ON THE PROMISE OF MIGS SAFE, CONSISTENT,

More information

Viscocanalostomy and Canaloplasty

Viscocanalostomy and Canaloplasty Viscocanalostomy and Canaloplasty Policy Number: 9.03.26 Last Review: 9/2014 Origination: 9/2012 Next Review: 9/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for

More information

DNB QUESTIONS 2014 PAPER 1. b) What are the Clinical Conditions in Which Nystagmus is Seen? c) Management of Nystagmus.

DNB QUESTIONS 2014 PAPER 1. b) What are the Clinical Conditions in Which Nystagmus is Seen? c) Management of Nystagmus. DNB QUESTIONS 2014 PAPER 1 1. a) How Will you investigate a case of Nystagmus? b) What are the Clinical Conditions in Which Nystagmus is Seen? c) Management of Nystagmus. 2. a) What is the Principle of

More information

II Ophthalmic Spring Academy. May 20 th -24 th 2014 Cracow, Hotel Galaxy

II Ophthalmic Spring Academy. May 20 th -24 th 2014 Cracow, Hotel Galaxy II Ophthalmic Spring Academy May 20 th -24 th 2014 Cracow, Hotel Galaxy Faculty: Lecturers of the phaco part: prof. Igor Loskutov prof. Marek Rękas prof. Frank Wilhelm prof. Tomasz Żarnowski II Ophthalmic

More information

Nirmals Eye Hospital. 108/5, Ayyasamy Street, Opp. Union Bank, West Tambaram, Chennai 45, Ph: /175,

Nirmals Eye Hospital. 108/5, Ayyasamy Street, Opp. Union Bank, West Tambaram, Chennai 45, Ph: /175, GLAUCOMA The Sneak Thief of your vision Nirmals Eye Hospital 108/5, Ayyasamy Street, Opp. Union Bank, West Tambaram, Chennai 45, Ph: 044-22266123 /175, 9841146062 www.nirmalseyehospital.com WHAT IS GLAUCOMA?

More information

Aqueous Shunts for the Treatment of Glaucoma

Aqueous Shunts for the Treatment of Glaucoma TITLE: Aqueous Shunts for the Treatment of Glaucoma AUTHOR: Jeffrey A. Tice, MD Assistant Professor of Medicine Division of General Internal Medicine Department of Medicine University of California San

More information

Correspondence should be addressed to Pedro Arriola-Villalobos; pedro

Correspondence should be addressed to Pedro Arriola-Villalobos; pedro Ophthalmology Volume 206, Article ID 056573, 7 pages http://dx.doi.org/0.55/206/056573 Clinical Study Glaukos istent inject Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients

More information

With the Presidency of Her Majesty the Queen Sofia

With the Presidency of Her Majesty the Queen Sofia ay, 21 st 10:00-15:00 Welcome and registration. Posters set-up With the Presidency of Her Majesty the Queen Sofia 12:00-12:15 OFFICIAL OPENING 12:15-13:15 KEYNOTE LECTURE Introduced by: Jesús Ávila. Bengt

More information

Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trial

Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trial Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trial Jose I. Belda, 1 Jordi Loscos-Arenas, 2 Andre Mermoud, 3

More information